Remdesivir—Bringing Hope for COVID-19 Treatment
At the beginning of 2020, the world was swept with a wave of a new coronavirus disease, named COVID-19 by the World Health Organization (WHO 2). The causative agent of this infection is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The data available on one of the promising thera...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Scientia Pharmaceutica |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-0532/88/2/29 |